[HTML][HTML] Biology, risk stratification, and therapy of pediatric acute leukemias: an update

…, WL Carroll, S Meshinchi, RJ Arceci - Journal of clinical …, 2011 - ncbi.nlm.nih.gov
Purpose We review recent advances in the biologic understanding and treatment of
childhood acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), identify …

Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance.

DM Bradshaw, RJ Arceci - Journal of Clinical Oncology, 1998 - ascopubs.org
For cytotoxic agents to have an effect on tumor cells, drugs must first be transported into the
cell, potentially be metabolized to an active form, and interact appropriately with target …

Central nervous system disease in Langerhans cell histiocytosis

N Grois, B Fahrner, RJ Arceci, JI Henter… - The Journal of …, 2010 - jpeds.com
Langerhans cell histiocytosis (LCH) is a rare disease of the monocyte-macrophage system.
The clinical presentation ranges from a single bone lesion to widespread multiorgan …

Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart

RJ Arceci, AAJ King, MC Simon, SH Orkin… - … and cellular biology, 1993 - Am Soc Microbiol
We report the cDNA cloning and characterization of mouse GATA-4, a new member of the
family of zinc finger transcription factors that bind a core GATA motif. GATA-4 cDNA was …

The Three Mouse Multidrug Resistance (mdr) Genes Are Expressed in a Tissue-Specific Manner in Normal Mouse Tissues

…, D Haber, A Devault, RJ Arceci… - … and cellular biology, 1989 - Taylor & Francis
The gene responsible for multidrug resistance (mdr), which encodes the P-glycoprotein, is a
member of a multigene family. We have identified distinct mdr gene transcripts encoded by …

The multidrug resistance (mdr1) gene product functions as an ATP channel.

…, L Gerweck, T Seneveratne, RJ Arceci… - Proceedings of the …, 1993 - National Acad Sciences
The multidrug resistance (mdr1) gene product, P-glycoprotein, is responsible for the ATP-dependent
extrusion of a variety of compounds, including chemotherapeutic drugs, from cells. …

Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection.

U Utans, RJ Arceci, Y Yamashita… - The Journal of clinical …, 1995 - Am Soc Clin Investig
The development of arteriosclerotic lesions in the Lewis to F344 rat model of chronic cardiac
rejection is characterized by macrophage adhesion to the vessel lumen and macrophage …

[HTML][HTML] The majority of total nuclear-encoded non-ribosomal RNA in a human cell is' dark matter'un-annotated RNA

…, PHB Sorensen, G Reaman, P Milos, RJ Arceci… - BMC biology, 2010 - Springer
Background Discovery that the transcriptional output of the human genome is far more
complex than predicted by the current set of protein-coding annotations and that most RNAs …

Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group

…, NA Heerema, C Arndt, RJ Arceci… - Blood, The Journal …, 2008 - ashpublications.org
CCG-2961 incorporated 3 new agents, idarubicin, fludarabine and interleukin-2, into a
phase 3 AML trial using intensive-timing remission induction/consolidation and related donor …

[PDF][PDF] Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

…, S Rheingold, K Ritchey, E Albano, RJ Arceci… - J Clin Oncol, 2006 - academia.edu
ArceciArceci, Stewart Goldman, Timothy Griffin, Arnold Altman, Bruce Gordon, Laurel
Steinherz, Steven Weitman, Peter Steinherz Data analysis and interpretation: Sima Jeha …